Federal regulators say a North Carolina compounding pharmacy, Apothecary Pharma, has pulled 23 vials of injectable drugs from the market over concerns they may not be sterile. The recall covers 22 Compounding Pharmacy's Sterility Lapses Trigger Nationwide Tirzepatide RecallRead more